Podcast episode 39 (in German)
Melanotan 2: the tanning peptide fact-checked
August 14, 2026
Melanotan 2 makes the skin turn brown without lying in the sun for hours. The peptide from the 1980s is the ancestor of no fewer than two approved drugs but never became one itself, and it carries a risk you need to know about.
What it is about
Melanotan 2 was developed at the University of Arizona, where researchers led by Victor Hruby and Mac Hadley wanted to prevent skin cancer by tanning the skin before sun exposure. It is a stable, ring-shaped copy of the hormone alpha-MSH and acts on several melanocortin receptors: in the skin on tanning, in the brain on appetite and desire. The episode tells how the sister peptide became a drug for a rare light-sensitivity disease and how a self-experiment led to a treatment for low sexual desire in women. It goes through the early human studies and dermatologists’ concerns about moles. What remains is probably the strongest known tanning signal, with a clear risk profile.
Key points
- The first human study by Dorr and colleagues, Life Sciences 1996, showed measurably darker skin after only 5 days of injections, without appreciable sun exposure.
- In 1998, Wessells and colleagues found in the Journal of Urology that Melanotan 2 triggered spontaneous erections in the majority of cases in men with erectile dysfunction.
- The sister substance Melanotan 1 is approved in Europe and the US as afamelanotide, as an implant for erythropoietic protoporphyria.
- The Melanotan 2 derivative bremelanotide became PT-141, approved in the US since 2019 as Vyleesi for low sexual desire in women.
- Of 5 melanocortin receptors, 2 are central: MC1R controls tanning, MC4R in the hypothalamus controls appetite and sexual arousal.
- As a report: users describe a deep, even tan with little sun, including people with fair skin types, plus dampened hunger in the first weeks.
Where the data stop
The human data come from two small studies from the 1990s. The main problem is moles: Melanotan 2 can make existing ones darker or larger and cause new spots to appear; Langan and colleagues described this in case series in 2010. This makes early detection of melanoma more difficult. There are case reports of melanomas in users; a causal link has not been proven. Anyone with many or conspicuous moles or a family history of skin cancer should stay away from it; everyone else should have their skin examined beforehand and regularly.
Added to this are nausea, facial flushing and, rarely, a persistent erection, which is an emergency. A peptide tan does not replace sunscreen. Melanotan 2 is not approved as a medicine, and its sale as a tanning agent is prohibited in Germany and the EU, as of August 2026.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on August 14, 2026.
The topic in the database
- A melanocortin peptide that stimulates skin tanning (often with little UV) and additionally influences appetite and libido via MC4R – in the scene for the…Melanotan 2
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.